HAI Solutions Issued U.S. Patent for RFID-Enabled QIKcap Platform

QIKcap® System QIKcap is HAI Solutions' ultraviolet platform for needle-free IV connectors, built to support more consistent connector care in the hospital.

CARLSBAD, Calif., Oct. 5, 2026 /PRNewswire/ -- Issued Patent Advances an AI-Enabled Platform for IV Connector CareHAI Solutions, a medical device company focused on intravenous therapy and vascular access, announced today that the United States Patent and Trademark Office has issued U.S. Patent 12,714,760, "Sterilization device." The patent, issued August 25, 2026, and assigned to HAI Solutions, covers RFID integration for the company's QIKcap platform.

"Our team is building technology that helps nurses do the right thing for every connector, every time," said Nicholas Perrenoud, Chief Executive Officer of HAI Solutions. "This patent strengthens the path to an AI-enabled QIKcap platform, one that supports compliance, takes friction out of the workflow, and gives clinical teams a clearer picture of care at the bedside."

The issued patent adds to the intellectual property behind QIKcap, HAI Solutions' FDA De Novo–granted system for microbial reduction on needle-free luer connectors. An RFID-enabled cap gives each accessory a distinct identity. Paired with an AI-enabled device platform, that identity is the basis for better compliance visibility, simpler nursing workflow, and more consistent IV connector care across the ICU, the operating room, the emergency department, and the floor. The aim is practical: fewer missed steps, less variability between shifts, and support for the nurses who carry connector maintenance all day.

"We are pleased to add this patent to a portfolio aimed at the daily work of IV care," said Paul Swaney, Chief Operating Officer of HAI Solutions. "An RFID cap and an AI-enabled QIKcap platform are about helping nursing practice, improving compliance, and protecting the patient on the other end of the line."

QIKcap, scheduled for a commercial launch in February 2027, is currently accepting pre-orders. To join the waitlist, contact the HAI Solutions team.

About HAI Solutions

Based in Carlsbad, California, HAI Solutions is developing a novel and diverse platform of innovative intravenous therapy solutions targeting IV contamination for the operating room, intensive care unit, and emergency room. We believe in protecting every patient by building innovative medical devices that address the challenges and pitfalls associated with intravenous care and vascular access. We are advancing clinical care across the healthcare spectrum.

For More Information Contact (Media): [email protected]

SOURCE HAI Solutions INC